AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
CorMedix's 15-minute chart triggers KDJ Death Cross, Bearish Marubozu formation.
ByAinvest
Wednesday, Jul 16, 2025 10:04 am ET1min read
According to the 15-minute chart for CorMedix, a technical analysis indicator called the KDJ Death Cross has been triggered. This indicator suggests that the momentum of the stock price is shifting towards the downside, and there is potential for further decreases in the stock price. The bearish Marubozu at 07/16/2025 10:00 indicates that sellers are currently in control of the market, and that the bearish momentum is likely to continue.
CorMedix Inc. (CRMD), a pharmaceutical and medical device company, has consistently exceeded earnings estimates in recent quarters. According to Zacks Investment Research [1], CorMedix topped estimates by an average of 24.71% over the last two quarters. For the most recent quarter, the company reported earnings of $0.3 per share, surpassing the Zacks Consensus Estimate of $0.25 per share by 20.00%. The previous quarter also saw CorMedix beat estimates by 29.41%, posting earnings of $0.22 per share against an expected $0.17 per share.The company's positive Earnings ESP (Expected Surprise Prediction) of +20.00% suggests that analysts have become bullish on CorMedix's earnings prospects. This indicator, when combined with the stock's Zacks Rank #3 (Hold), increases the likelihood of another earnings beat. Zacks Investment Research notes that stocks with this combination have a 70% chance of beating the consensus estimate [1].
However, technical analysis indicates potential headwinds for CorMedix. According to a 15-minute chart, the KDJ Death Cross has been triggered, signaling a shift in momentum towards the downside. Additionally, a bearish Marubozu on July 16, 2025, suggests that sellers are currently in control of the market, potentially leading to further price decreases.
Investors should monitor CorMedix's earnings report closely, as the company's ability to maintain its earnings beat streak remains crucial. The technical indicators, while not definitive, provide additional context for potential price movements.
References:
[1] https://www.nasdaq.com/articles/can-cormedix-crmd-keep-earnings-surprise-streak-alive
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet